CERo Therapeutics Holdings, Inc. Share Price
Equities
CERO
US71902K1051
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 USD | +1.46% | -2.11% | -87.36% |
04-02 | CERo Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-11 | Top Premarket Decliners | MT |
Sales 2022 | - | Sales 2023 | - | Capitalization | 68.71M 5.47B |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -2M -159M | EV / Sales 2022 | - |
Net Debt 2022 | 174K 13.87M | Net Debt 2023 | 1.46M 116M | EV / Sales 2023 | - |
P/E ratio 2022 |
-346
x | P/E ratio 2023 |
-28.3
x | Employees | 9 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 48.77% |
1 day | +1.46% | ||
1 week | -2.11% | ||
Current month | -54.72% | ||
1 month | -54.72% | ||
3 months | -87.40% | ||
6 months | -87.21% | ||
Current year | -87.36% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.29% | 15 M€ | -0.52% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 1.39 | +1.46% | 40,428 |
26/04/24 | 1.37 | -2.84% | 94,318 |
25/04/24 | 1.41 | -3.15% | 83,210 |
24/04/24 | 1.456 | +7.84% | 265,827 |
23/04/24 | 1.35 | -4.93% | 108,840 |
Delayed Quote Nasdaq, April 29, 2024 at 09:30 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-87.36% | 20.17M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- CERO Stock